A Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety and Efficacy of 3VM1001 Cream for the Treatment of Chronic Pain Caused by Osteoarthritis of the Knee: A Dose Ranging Study
Phase of Trial: Phase I/II
Latest Information Update: 16 Jul 2018
At a glance
- Drugs 3VM 1001 (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors CDA Research Group
- 04 Apr 2018 Status changed from recruiting to completed.
- 29 Dec 2017 Planned primary completion date changed from 30 Oct 2017 to 30 Jan 2018.
- 10 May 2017 New trial record